On March 18–19, LithuaniaBIO, together with Lithuanian life sciences companies – Caszyme, Nando, Biomapas, VUGENE, LAIMA and Vital 3D Technologies – participated in Advanced Therapies Congress, the largest commercial cell and gene therapy conference and exhibition in Europe, held in London.
The event brought together executives and top-level leaders from ATMP (Advanced Therapy Medicinal Products) companies, driving the latest technologies and strategies that advance the industry.
Throughout the congress, we established valuable connections, expanded partnerships, and strengthened ties with international life sciences professionals. It was also a great opportunity to explore the latest advancements and cutting-edge biotech innovations.
In addition, Lithuanian representatives took part in the biotech networking event, “From Pink Soup to Afternoon Tea: Connecting Lithuanian and UK BioTech Innovators,” organized by Innovation Agency Lithuania and MedCity. Agency Lithuania and MedCity. This event brought together biotech representatives and innovators from Lithuania and the UK, providing a platform to showcase expertise, exchange insights, and discuss emerging trends in biotechnology.
The event was a great opportunity for biotech leaders and business representatives to connect and build strategic international partnerships
The participation of Lithuanian companies in these events was implemented according to the according to the project “Participation of Lithuanian Life Sciences Companies in International Exhibitions” (No. 11-04-16.2.1.K-007) within the measure “Promoting the Growth of Export Competitiveness of Lithuanian Companies through the Implementation of International Partnership Development Initiatives” (No. 05-001-01-11-04).
